Elastomeric Pumps Market - Global Forecast To 2030
商品番号 : SMB-90893
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年11月 |
| ページ数 | 242 |
| 図表数 | 235 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
エラストマー輸液ポンプ市場 – タイプ（持続レートと変動レート）、用途（化学療法、疼痛管理、抗生物質）、最終用途産業（病院、外来手術センター、在宅ケア環境）、および地域別 – 2030年までの世界予測
エラストマー輸液ポンプ市場は、予測期間中に5.3%のCAGRで成長し、2025年の11億5,000万米ドルから2030年には14億9,000万米ドルに達すると予想されています。
エラストマー輸液ポンプ市場は、医療従事者と患者が正確で持続的な薬剤投与のために携帯型の非電子デバイスを利用するケースが増えていることから、着実な成長が見込まれています。腫瘍学、疼痛管理、麻酔、在宅ケアにおける需要の増加は、患者中心で歩行可能な簡素化された輸液ソリューションへのニーズに牽引され、市場の成長に貢献しています。これらのデバイスは、バッテリーや複雑な回路を必要とせず、信頼性と精度の高い薬剤投与を提供し、患者の移動性とコンプライアンスを向上させます。欧州医薬品庁（EMA）や米国食品医薬品局（FDA）などの規制当局、そして複数の地域保健機関は、安全性、品質、生体適合性に関するより厳格な要件を導入しています。これにより、メーカーは新たなマルチチャンバー設計、フロー制御システム、そしてより優れたエラストマーの開発を迫られています。医療廃棄物の削減に向けた最新の技術革新には、リアルタイムの投薬量モニタリング、インテリジェントモニタリングシステムとの統合、そしてリサイクル可能な環境に優しい材料の活用が含まれます。
本調査レポートは、エラストマー輸液ポンプ市場を、タイプ（連続速度型と可変速度型）、用途（疼痛管理、抗生物質、化学療法、その他の用途）、および最終用途産業（病院、外来手術センター（ASC）、在宅ケア施設、その他の最終用途産業）に基づいて分類しています。レポートは、エラストマー輸液ポンプ市場の成長に影響を与える推進要因、制約要因、課題、機会に関する詳細な情報を網羅しています。主要業界プレーヤーの詳細な分析を実施し、エラストマー輸液ポンプ市場に関連する事業概要、提供製品、主要戦略（提携、コラボレーション、合併、買収、事業拡大など）に関する洞察を提供しています。本レポートは、エラストマー輸液ポンプ市場エコシステムにおける新興企業の競合分析も網羅しています。
本レポートは、市場リーダーおよび新規参入企業に対し、エラストマー輸液ポンプ市場全体とそのサブセグメントの収益数値に関する近似値を提供します。本レポートは、ステークホルダーが競争環境を理解し、事業をより効果的にポジショニングするためのより深い洞察を獲得し、適切な市場開拓戦略を策定するのに役立ちます。また、本レポートは、ステークホルダーが市場の動向を把握し、主要な市場牽引要因、制約要因、課題、そして機会に関する情報を提供するのに役立ちます。
本レポートでは、以下の点について洞察を提供しています。
- 主要な推進要因（慢性疾患の有病率上昇、外来および在宅ケアへの移行拡大、使い捨ておよびポータブル設計）、制約要因（薬剤投与ミスや性能変動のリスク上昇、エラストマーポンプの信頼性に関する規制当局によるリコール、厳格な規制承認およびコンプライアンス要件）、機会（新興国における医療技術の進歩、高粘度薬剤および生物学的製剤への特化）、課題（電子輸液技術との熾烈な競争、大規模エラストマーポンプ生産における精度と安全性の維持）の分析。
- 製品開発／イノベーション：エラストマー輸液ポンプ市場における今後の技術、研究開発活動、製品・サービスの投入に関する詳細な洞察。
- 市場開発：収益性の高い市場に関する包括的な情報。本レポートでは、様々な地域におけるエラストマー輸液ポンプ市場を分析しています。
- 市場の多様化：エラストマー輸液ポンプ市場における新製品・サービス、未開拓地域、最近の動向、投資に関する包括的な情報。
- 競合評価：バクスター（米国）、B. Braun SE（ドイツ）、NIPRO（日本）、AVNS（米国）、Vygon（フランス）、WOOYOUNG MEDICAL CO., LTD.（韓国）、Shanghai INT Medical Instruments Co., Ltd.（中国）、Ambu A/S（デンマーク）、Palex（スペイン）、DAIKEN MEDICAL CO., LTD.といった主要企業の市場シェア、成長戦略、サービス提供に関する詳細な評価。 （日本）など。
Report Overview
The elastomeric infusion pumps market is expected to reach USD 1.49 billion by 2030 from USD 1.15 billion in 2025, at a CAGR of 5.3% during the forecast period.
The elastomeric infusion pumps market is projected for steady growth as healthcare providers and patients increasingly utilize portable, non-electronic devices for accurate, continuous drug administration. The increasing demand in oncology, pain management, anesthesia, and home care contributes to market growth, driven by the need for patient-centric, ambulatory, and simplified infusion solutions. These devices provide reliable and accurate medicine delivery without requiring batteries or complex circuitry, thereby improving patient mobility and compliance. Regulatory entities, such as the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA), as well as several regional health organizations, have implemented more stringent requirements for safety, quality, and biocompatibility. This is pushing manufacturers to develop new multi-chamber designs, flow control systems, and better elastomers. To mitigate medical waste, current advancements encompass real-time dosage monitoring, integration with intelligent monitoring systems, and the utilization of recyclable, eco-friendly materials.
“Pain Management accounted for the largest share in the elastomeric infusion pumps market in 2024.”
Pain management accounted for the largest share of the elastomeric infusion pumps market in 2024, driven by their widespread use in surgical and chronic pain treatments. These pumps provide a continuous, controlled dosage of analgesics like morphine or fentanyl, ensuring efficient reduction of pain while reducing hospital stays. Their portability, user-friendliness, and capacity to deliver consistent drug infusion without technological components render them optimal for both inpatient and home-care environments. The rise in surgical procedures, along with an increased focus on patient comfort and mobility, enhances their use in pain treatment applications.
“Hospitals accounted for the largest share of the elastomeric infusion pumps market in 2024.”
In 2024, hospitals represented the largest segment of the elastomeric infusion pumps market, driven by a significant need for reliable and continuous drug delivery systems across various therapies. These pumps are extensively used for postoperative analgesia, chemotherapy, and antibiotic delivery, providing continuous infusion that is independent of electronic components or external power sources. Their disposable and sterile design complies with hospital infection control requirements, thereby reducing the risk of cross-contamination and the need for device maintenance. Additionally, the increasing number of surgeries, the focus on expediting patient recovery, and patients’ preference for less-expensive infusion solutions have all contributed to their growing prevalence in hospitals. Elastomeric pumps are important tools for modern hospital-based patient care as they are easy to use, safe, and accurate.
“North America dominated the regional market for elastomeric infusion pumps in 2024.”
In 2024, the elastomeric infusion pumps market was primarily concentrated in North America due to an advanced healthcare system, widespread adoption of cutting-edge medical devices, and a heightened incidence of chronic conditions, such as cancer, cardiovascular disease, and diabetes. Many of the benefits in this region stem from strong reimbursement policies, enabling policies, and increasing outpatient and home care service patterns, all of which heavily promote the development of portable and simple-to-use infusion systems. The continued existence of market leaders in a good overall position, with ample development of conducive factors, created further opportunities for market leadership development. In addition, hospitals and specialist clinics continuously utilize elastomeric pumps to provide continuous, allowed, high-dose drug delivery for the management of pain and for post-surgery comfort, which creates both patient comfort and cost-saving measures against hospitalization.
- By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30%
- By Designation: Directors: 30%, Managers: 20%, and Others: 50%
- By Region: North America: 20%, Europe: 10%, Asia Pacific: 40%, South America: 10%, and Middle East & Africa 20%
Notes: Others include sales, marketing, and product managers.
Tier 1: >USD 1 Billion; Tier 2: USD 500 million–1 Billion; and Tier 3: <USD 500 million
Companies Covered: Baxter (US), B. Braun SE (Germany), NIPRO (Japan), AVNS (US), Vygon (France), WOOYOUNG MEDICAL CO., LTD. (South Korea), Shanghai INT Medical Instruments Co., Ltd. (China), Ambu A/S (Denmark), Palex (Spain), and DAIKEN MEDICAL CO., LTD. (Japan) are covered in the report.
The study includes an in-depth competitive analysis of these key players in the elastomeric infusion pumps market, with their company profiles, recent developments, and key market strategies.
Research Coverage
This research report categorizes the elastomeric infusion pumps market based on type (Continuous Rate and Variable Rate), application (Pain Management, Antibiotics, Chemotherapy, and Other Applications), and end-use industry (Hospitals, Ambulatory Surgical Centers (ASCs), Home-care Settings, and Other End-use Industries). The report’s scope encompasses detailed information regarding the drivers, restraints, challenges, and opportunities that influence the growth of the elastomeric infusion pumps market. A detailed analysis of key industry players has been conducted to provide insights into their business overview, products offered, and key strategies, including partnerships, collaborations, mergers, acquisitions, and expansions, associated with the elastomeric infusion pumps market. This report covers a competitive analysis of upcoming startups in the elastomeric infusion pumps market ecosystem.
Reasons to Buy the Report
The report will provide market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall elastomeric infusion pumps market and its subsegments. This report will help stakeholders understand the competitive landscape, gain deeper insights into positioning their businesses more effectively, and develop suitable go-to-market strategies. The report will help stakeholders understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights into the following points:
- Analysis of key drivers (rising prevalence of chronic diseases, growing shift to ambulatory and home-based care, and disposable and portable design), restraints (rising risks of incorrect drug delivery and performance variability, regulatory recalls on elastomeric pump reliability, and stringent regulatory approvals and compliance requirements), opportunities (rising healthcare advancements in emerging economies, and specialization for high-viscosity drugs and biologics), and challenges (intense competition with electronic infusion technologies and maintaining precision and safety in scaled elastomeric pump production).
- Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and product & service launches in the elastomeric infusion pumps market.
- Market Development: Comprehensive information about profitable markets – the report analyzes the elastomeric infusion pumps market across varied regions.
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the elastomeric infusion pumps market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Baxter (US), B. Braun SE (Germany), NIPRO (Japan), AVNS (US), Vygon (France), WOOYOUNG MEDICAL CO., LTD. (South Korea), Shanghai INT Medical Instruments Co., Ltd. (China), Ambu A/S (Denmark), Palex (Spain), and DAIKEN MEDICAL CO., LTD. (Japan), among others.
Table of Contents
1 INTRODUCTION 22
1.1 STUDY OBJECTIVES 22
1.2 MARKET DEFINITION 22
1.3 STUDY SCOPE 23
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 23
1.3.2 INCLUSIONS AND EXCLUSIONS 24
1.3.3 YEARS CONSIDERED 24
1.3.4 CURRENCY CONSIDERED 25
1.3.5 UNITS CONSIDERED 25
1.4 STAKEHOLDERS 25
2 EXECUTIVE SUMMARY 26
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 26
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 27
2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH 28
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 29
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 30
3 PREMIUM INSIGHTS 31
3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN ELASTOMERIC INFUSION
PUMPS MARKET 31
3.2 NORTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE AND COUNTRY 32
3.3 ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE 32
3.4 ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION 33
3.5 ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY 33
3.6 ELASTOMERIC INFUSION PUMPS MARKET, BY COUNTRY 34
4 MARKET OVERVIEW 35
4.1 INTRODUCTION 35
4.2 MARKET DYNAMICS 35
4.2.1 DRIVERS 36
4.2.1.1 Rising prevalence of chronic diseases 36
4.2.1.2 Growing shift to ambulatory and home-based care 37
4.2.1.3 Disposable and portable design 37
4.2.2 RESTRAINTS 38
4.2.2.1 Rising risks of incorrect drug delivery and performance variability 38
4.2.2.2 Regulatory recalls on elastomeric pump reliability 38
4.2.2.3 Stringent regulatory approvals and compliance requirements 39
4.2.3 OPPORTUNITIES 39
4.2.3.1 Rising healthcare advancements in emerging economies 39
4.2.3.2 Specialization for high-viscosity drugs and biologics 40
4.2.4 CHALLENGES 41
4.2.4.1 Intense competition with electronic infusion technologies 41
4.2.4.2 Maintaining precision and safety in scaled elastomeric
pump production 41
4.3 UNMET NEEDS AND WHITE SPACES 42
4.3.1 UNMET NEEDS IN ELASTOMERIC INFUSION PUMPS MARKET 42
4.3.2 WHITE SPACE OPPORTUNITIES 42
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 43
4.4.1 INTERCONNECTED MARKETS 43
4.4.2 CROSS-SECTOR OPPORTUNITIES 43
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 44
4.5.1 KEY MOVES AND STRATEGIC FOCUS 44
5 INDUSTRY TRENDS 45
5.1 PORTER’S FIVE FORCES ANALYSIS 45
5.1.1 THREAT OF NEW ENTRANTS 46
5.1.2 THREAT OF SUBSTITUTES 46
5.1.3 BARGAINING POWER OF SUPPLIERS 47
5.1.4 BARGAINING POWER OF BUYERS 47
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 47
5.2 MACROECONOMIC ANALYSIS 48
5.2.1 INTRODUCTION 48
5.2.2 GDP TRENDS AND FORECASTS 48
5.3 VALUE CHAIN ANALYSIS 48
5.4 ECOSYSTEM ANALYSIS 50
5.5 PRICING ANALYSIS 52
5.5.1 AVERAGE SELLING PRICE OF ELASTOMERIC INFUSION PUMPS, BY TYPE 52
5.5.2 AVERAGE SELLING PRICE ANALYSIS, BY REGION 53
5.6 TRADE ANALYSIS 53
5.6.1 EXPORT SCENARIO (HS CODE 901890) 53
5.6.2 IMPORT SCENARIO (HS CODE 901890) 54
5.7 KEY CONFERENCES AND EVENTS, 2025–2026 56
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 56
5.8.1 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 56
5.9 INVESTMENT AND FUNDING SCENARIO 58
5.10 CASE STUDY ANALYSIS 58
5.10.1 MOBILITY ENHANCEMENT IN INFUSION THERAPY USING SUREFUSER+ PUMP 58
5.10.2 COST-SAVING POTENTIAL OF ELASTOMERIC PUMPS IN POSTOPERATIVE
PAIN THERAPY 59
5.10.3 IMPROVED QUALITY OF LIFE IN CHEMOTHERAPY WITH SUREFUSER+ PUMP 60
5.11 IMPACT OF 2025 US TARIFF: ELASTOMERIC INFUSION PUMPS MARKET 60
5.11.1 INTRODUCTION 60
5.11.2 KEY TARIFF RATES 60
5.11.3 PRICE IMPACT ANALYSIS 61
5.11.4 IMPACT ON COUNTRIES/REGIONS 62
5.11.4.1 US 62
5.11.4.2 China 62
5.11.4.3 Europe 62
5.11.4.4 Brazil 62
5.11.5 IMPACT ON END-USE INDUSTRIES 63
6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL,
AND AI ADOPTIONS 64
6.1 KEY EMERGING TECHNOLOGIES 64
6.1.1 PRECISION FLOW CONTROL SYSTEMS AND MULTI-RATE DESIGNS 64
6.1.2 ADVANCED MATERIALS FOR DRUG STABILITY 64
6.1.3 ELASTOMERIC MEMBRANE FOR PRESSURE GENERATION 65
6.2 COMPLEMENTARY TECHNOLOGIES 65
6.2.1 ANTIMICROBIAL AND BIOCOMPATIBLE MATERIALS 65
6.3 ADJACENT TECHNOLOGIES 66
6.3.1 SMART CONNECTIVITY AND IOT INTEGRATION 66
6.4 TECHNOLOGY/PRODUCT ROADMAP 66
6.4.1 SHORT-TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION 66
6.4.2 MID-TERM (2027–2030) | EXPANSION & INTEGRATION 67
6.4.3 LONG-TERM (2030–2035+) | MATURITY & AUTONOMOUS SYSTEMS 67
6.5 PATENT ANALYSIS 68
6.5.1 INTRODUCTION 68
6.5.2 METHODOLOGY 68
6.5.3 ELASTOMERIC INFUSION PUMPS MARKET, PATENT ANALYSIS, 2015–2024 68
6.6 FUTURE APPLICATIONS 72
6.6.1 INTEGRATION WITH DIGITAL HEALTH FOR REMOTE MONITORING 72
6.6.2 EXPANSION INTO VETERINARY AMBULATORY CARE 72
6.6.3 DELIVERY OF ADVANCED THERAPEUTICS LIKE BIOLOGICS
AND GENE THERAPY 73
6.6.4 BIOLUMINESCENT INDICATOR FILMS 73
6.7 IMPACT OF AI/GEN AI ON ELASTOMERIC INFUSION PUMPS MARKET 74
6.7.1 TOP USE CASES AND MARKET POTENTIAL 74
6.7.2 BEST PRACTICES IN ELASTOMERIC INFUSION PUMP PROCESSING 75
6.7.3 CASE STUDIES OF AI IMPLEMENTATION IN ELASTOMERIC INFUSION
PUMPS MARKET 75
6.7.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON
MARKET PLAYERS 75
6.7.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN ELASTOMERIC
INFUSION PUMPS MARKET 76
6.8 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 76
6.8.1 UNIVERSITY OF MICHIGAN DEPLOYS DOSI-FUSER ELASTOMERIC INFUSION SYSTEM FOR HOME CHEMOTHERAPY 76
6.8.2 PEDIATRIC HOME CHEMOTHERAPY (INTACT@HOME, CANADA) 77
6.8.3 PALLIATIVE CARE AND END-OF-LIFE SYMPTOM MANAGEMENT
(SOUTHERN ONTARIO, CANADA) 77
7 SUSTAINABILITY AND REGULATORY LANDSCAPE 78
7.1 REGIONAL REGULATIONS AND COMPLIANCE 78
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND
OTHER ORGANIZATIONS 78
7.1.2 INDUSTRY STANDARDS 82
7.2 SUSTAINABILITY INITIATIVES 83
7.2.1 CARBON IMPACT AND ECO-APPLICATIONS OF ELASTOMERIC
INFUSION PUMPS 83
7.2.1.1 Carbon impact reduction 83
7.2.1.2 Eco-applications 84
7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 84
7.4 CERTIFICATIONS, LABELING, ECO-STANDARDS 85
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 86
8.1 DECISION-MAKING PROCESS 86
8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 88
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 88
8.2.2 BUYING CRITERIA 89
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 89
8.4 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES 90
8.5 MARKET PROFITABILITY 91
8.5.1 REVENUE POTENTIAL 91
8.5.2 COST DYNAMICS 91
8.5.3 MARGIN OPPORTUNITIES, BY APPLICATION 92
9 ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE 93
9.1 INTRODUCTION 94
9.2 CONTINUOUS RATE 94
9.2.1 DEMAND FOR PRECISE, PORTABLE, AND POWER-FREE DRUG DELIVERY
IN OUTPATIENT CARE TO DRIVE MARKET 94
9.3 VARIABLE RATE 95
9.3.1 RISING NEED FOR PERSONALIZED AND ADJUSTABLE DRUG DELIVERY
IN AMBULATORY CARE TO DRIVE DEMAND 95
10 ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION 96
10.1 INTRODUCTION 97
10.2 CHEMOTHERAPY 98
10.2.1 RISING CANCER INCIDENCE AND SHIFT TOWARD OUTPATIENT CHEMOTHERAPY DRIVING ADOPTION 98
10.3 PAIN MANAGEMENT 98
10.3.1 RISING PREVALENCE OF CHRONIC PAIN AND DEMAND FOR OUTPATIENT ANALGESIC DELIVERY TO SUPPORT MARKET GROWTH 98
10.4 ANTIBIOTICS 99
10.4.1 GROWTH OF OUTPATIENT ANTIBIOTIC THERAPY AND HOME-BASED CARE DRIVING ADOPTION 99
10.5 OTHER APPLICATIONS 99
11 ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY 100
11.1 INTRODUCTION 101
11.2 HOSPITALS 102
11.2.1 NEED FOR ENHANCING PATIENT CARE AND OPERATIONAL EFFICIENCY
TO DRIVE MARKET 102
11.3 AMBULATORY SURGICAL CENTERS (ASCS) 102
11.3.1 OFFERS OPTIMIZED OUTPATIENT SURGICAL CARE WITH EFFICIENT
DRUG DELIVERY 102
11.4 HOMECARE SETTINGS 103
11.4.1 INCREASING DEMAND FOR SAFE AND INDEPENDENT HOME-
BASED CARE TO DRIVE MARKET 103
11.5 OTHER END-USE INDUSTRIES 103
12 ELASTOMERIC INFUSION PUMPS MARKET, BY REGION 104
12.1 INTRODUCTION 105
12.2 NORTH AMERICA 107
12.2.1 US 109
12.2.1.1 Rising cancer prevalence driving demand for continuous
infusion therapies 109
12.2.2 CANADA 111
12.2.2.1 Aging population and increasing cancer cases propelling growth 111
12.2.3 MEXICO 112
12.2.3.1 Government health initiatives and rising chronic disease
burden to boost demand 112
12.3 EUROPE 114
12.3.1 GERMANY 116
12.3.1.1 Strong healthcare infrastructure and growing preference for
home-based care to drive demand 116
12.3.2 FRANCE 118
12.3.2.1 Rising oncology cases and preference for outpatient care to
boost market growth 118
12.3.3 UK 119
12.3.3.1 Strong healthcare infrastructure and rising cancer burden
driving demand 119
12.3.4 ITALY 121
12.3.4.1 Increasing chronic pain burden driving adoption 121
12.3.5 SPAIN 122
12.3.5.1 Rising cancer incidence and aging population fueling demand 122
12.3.6 REST OF EUROPE 124
12.4 ASIA PACIFIC 125
12.4.1 CHINA 127
12.4.1.1 Growing hospital infrastructure and rising outpatient care
fueling adoption 127
12.4.2 JAPAN 129
12.4.2.1 Growing aging population to support market growth 129
12.4.3 INDIA 130
12.4.3.1 Expanding cancer care infrastructure and home-based
treatment driving adoption 130
12.4.4 SOUTH KOREA 132
12.4.4.1 Rising healthcare needs and technological integration to
accelerate market growth 132
12.4.5 AUSTRALIA 133
12.4.5.1 Increased healthcare spending driving market growth 133
12.4.6 REST OF ASIA PACIFIC 135
12.5 SOUTH AMERICA 136
12.5.1 BRAZIL 138
12.5.1.1 Government healthcare programs and expanding chronic care infrastructure propelling adoption 138
12.5.2 ARGENTINA 140
12.5.2.1 Expanding healthcare infrastructure and chronic disease management boosting adoption 140
12.5.3 REST OF SOUTH AMERICA 141
12.6 MIDDLE EAST & AFRICA 143
12.6.1 GCC COUNTRIES 145
12.6.1.1 Saudi Arabia 146
12.6.1.1.1 Healthcare transformation and localization initiatives
under Vision 2030 to accelerate demand 146
12.6.1.2 UAE 148
12.6.1.2.1 Expanding healthcare infrastructure fueling adoption
of elastomeric infusion pumps 148
12.6.1.3 Rest of GCC Countries 149
12.6.2 SOUTH AFRICA 151
12.6.2.1 National health insurance implementation and chronic care initiatives to fuel growth 151
12.6.3 REST OF MIDDLE EAST & AFRICA 152
13 COMPETITIVE LANDSCAPE 154
13.1 OVERVIEW 154
13.2 KEY PLAYERS’ STRATEGIES 154
13.3 MARKET SHARE ANALYSIS 156
13.4 REVENUE ANALYSIS 159
13.5 COMPANY VALUATION AND FINANCIAL METRICS 160
13.6 PRODUCT/BRAND COMPARISON 161
13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 163
13.7.1 STARS 163
13.7.2 EMERGING LEADERS 163
13.7.3 PERVASIVE PLAYERS 163
13.7.4 PARTICIPANTS 163
13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 165
13.7.5.1 Company footprint 165
13.7.5.2 Regional footprint 165
13.7.5.3 Type footprint 166
13.7.5.4 Application footprint 166
13.7.5.5 End-use industry footprint 167
13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 167
13.8.1 PROGRESSIVE COMPANIES 167
13.8.2 RESPONSIVE COMPANIES 167
13.8.3 DYNAMIC COMPANIES 168
13.8.4 STARTING BLOCKS 168
13.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 169
13.8.5.1 Detailed list of key startups/SMEs 169
13.8.5.2 Competitive benchmarking of key startups/SMEs 170
13.9 COMPETITIVE SCENARIO 172
13.9.1 DEALS 172
13.9.2 EXPANSIONS 173
14 COMPANY PROFILES 175
14.1 KEY PLAYERS 175
14.1.1 BAXTER 175
14.1.1.1 Business overview 175
14.1.1.2 Products/Solutions/Services offered 176
14.1.1.3 MnM view 178
14.1.1.3.1 Key strengths 178
14.1.1.3.2 Strategic choices 178
14.1.1.3.3 Weaknesses and competitive threats 178
14.1.2 B. BRAUN SE 179
14.1.2.1 Business overview 179
14.1.2.2 Products/Solutions/Services offered 180
14.1.2.3 Recent developments 182
14.1.2.3.1 Deals 182
14.1.2.4 MnM view 182
14.1.2.4.1 Key strengths 182
14.1.2.4.2 Strategic choices 182
14.1.2.4.3 Weaknesses and competitive threats 182
14.1.3 NIPRO 183
14.1.3.1 Business overview 183
14.1.3.2 Products/Solutions/Services offered 184
14.1.3.3 Recent developments 185
14.1.3.3.1 Deals 185
14.1.3.3.2 Expansions 186
14.1.3.4 MnM view 187
14.1.3.4.1 Key strengths 187
14.1.3.4.2 Strategic choices 187
14.1.3.4.3 Weaknesses and competitive threats 187
14.1.4 AVNS 188
14.1.4.1 Business overview 188
14.1.4.2 Products/Solutions/Services offered 189
14.1.4.3 MnM view 190
14.1.4.3.1 Key strengths 190
14.1.4.3.2 Strategic choices 190
14.1.4.3.3 Weaknesses and competitive threats 191
14.1.5 VYGON 192
14.1.5.1 Business overview 192
14.1.5.2 Products/Solutions/Services offered 192
14.1.5.3 Recent developments 193
14.1.5.3.1 Deals 193
14.1.5.3.2 Expansions 193
14.1.5.4 MnM view 193
14.1.5.4.1 Key strengths 193
14.1.5.4.2 Strategic choices 194
14.1.5.4.3 Weaknesses and competitive threats 194
14.1.6 WOOYOUNG MEDICAL CO., LTD. 195
14.1.6.1 Business overview 195
14.1.6.2 Products/Solutions/Services offered 195
14.1.6.3 MnM view 196
14.1.7 SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD. 197
14.1.7.1 Business overview 197
14.1.7.2 Products/Solutions/Services offered 198
14.1.7.3 Recent developments 199
14.1.7.3.1 Deals 199
14.1.7.4 MnM view 199
14.1.8 AMBU A/S 200
14.1.8.1 Business overview 200
14.1.8.2 Products/Solutions/Services offered 201
14.1.8.3 Recent developments 202
14.1.8.3.1 Expansions 202
14.1.8.4 MnM view 202
14.1.9 PALEX 203
14.1.9.1 Business overview 203
14.1.9.2 Products/Solutions/Services offered 203
14.1.9.3 Recent developments 204
14.1.9.3.1 Deals 204
14.1.9.4 MnM view 204
14.1.10 DAIKEN MEDICAL CO., LTD. 205
14.1.10.1 Business overview 205
14.1.10.2 Products/Solutions/Services offered 206
14.1.10.3 MnM view 206
14.2 OTHER PLAYERS 207
14.2.1 PROMECON GMBH 207
14.2.2 S&S MED 208
14.2.3 EPIC MEDICAL 209
14.2.4 MULTIMEDICAL S.R.L. 210
14.2.5 TECNOLINE S.P.A. 211
14.2.6 ZHEJIANG FERT MEDICAL DEVICE CO., LTD. 212
14.2.7 ACE MEDICAL 213
14.2.8 GAMASTECH SRL 214
14.2.9 FIRST MEDICAL SOURCE 215
14.2.10 DELTAMED 216
14.2.11 VIKYMED ITALIA SRL 217
14.2.12 CHANGZHOU MEDICAL BIOENGINEERING CO., LTD. 218
14.2.13 MAIS INDIA 219
14.2.14 NARANG MEDICAL LIMITED 220
14.2.15 ZEBRA MEDICAL 221
15 RESEARCH METHODOLOGY 222
15.1 RESEARCH DATA 222
15.1.1 SECONDARY DATA 223
15.1.1.1 Key data from secondary sources 223
15.1.2 PRIMARY DATA 223
15.1.2.1 Key data from primary sources 224
15.1.2.2 Key industry insights 224
15.2 MARKET SIZE ESTIMATION 225
15.3 BASE NUMBER CALCULATION 227
15.3.1 DEMAND-SIDE APPROACH 227
15.3.2 SUPPLY-SIDE APPROACH 227
15.4 MARKET FORECAST APPROACH 227
15.4.1 SUPPLY SIDE 227
15.4.2 DEMAND SIDE 228
15.5 DATA TRIANGULATION 228
15.6 FACTOR ANALYSIS 229
15.7 RESEARCH ASSUMPTIONS 229
15.8 RESEARCH LIMITATIONS AND RISK ASSESSMENT 230
16 ADJACENT & RELATED MARKETS 231
16.1 INTRODUCTION 231
16.2 LIMITATIONS 231
16.2.1 INFUSION PUMPS MARKET 231
16.2.1.1 Market definition 231
16.2.1.2 Infusion pumps market, by product 231
16.2.1.3 Infusion pumps market, by application 232
16.2.1.4 Infusion pumps market, by setting 233
16.2.1.5 Infusion pumps market, by region 233
17 APPENDIX 235
17.1 DISCUSSION GUIDE 235
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 238
17.3 CUSTOMIZATION OPTIONS 240
17.4 RELATED REPORTS 240
17.5 AUTHOR DETAILS 241
LIST OF TABLES
TABLE 1 ELASTOMERIC INFUSION PUMPS MARKET: IMPACT OF PORTER’S FIVE FORCES 46
TABLE 2 GLOBAL GDP GROWTH PROJECTION, BY REGION, 2021–2028 (USD TRILLION) 48
TABLE 3 ELASTOMERIC INFUSION PUMPS MARKET: ROLES OF COMPANIES IN ECOSYSTEM 51
TABLE 4 AVERAGE SELLING PRICE OF KEY PLAYERS, BY TYPE, 2024 (USD/UNIT) 52
TABLE 5 AVERAGE SELLING PRICE TREND OF ELASTOMERIC INFUSION PUMPS,
BY REGION, 2023–2030 (USD/UNIT) 53
TABLE 6 EXPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS,
BY COUNTRY, 2020–2024 (USD MILLION) 54
TABLE 7 IMPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS,
BY COUNTRY, 2020–2024 (USD MILLION) 55
TABLE 8 ELASTOMERIC INFUSION PUMPS MARKET: DETAILED LIST OF
CONFERENCES AND EVENTS, 2025–2026 56
TABLE 9 ELASTOMERIC INFUSION PUMPS MARKET: LIST OF KEY PATENTS, 2022–2024 70
TABLE 10 TOP USE CASES AND MARKET POTENTIAL 74
TABLE 11 BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES 75
TABLE 12 ELASTOMERIC INFUSION PUMPS MARKET: CASE STUDIES RELATED
TO GEN AI IMPLEMENTATION 75
TABLE 13 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS 78
TABLE 14 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS 79
TABLE 15 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS 80
TABLE 16 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT
AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS 81
TABLE 17 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS 82
TABLE 18 GLOBAL INDUSTRY STANDARDS IN ELASTOMERIC INFUSION PUMPS MARKET 82
TABLE 19 CERTIFICATIONS, LABELING, ECO-STANDARDS IN ELASTOMERIC
INFUSION PUMPS MARKET 85
TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END-USE INDUSTRY (%) 88
TABLE 21 KEY BUYING CRITERIA, BY END-USE INDUSTRY 89
TABLE 22 UNMET NEEDS IN ELASTOMERIC INFUSION PUMPS MARKET,
BY END-USE INDUSTRY 91
TABLE 23 ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 94
TABLE 24 ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 97
TABLE 25 ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY,
2023–2030 (USD MILLION) 101
TABLE 26 ELASTOMERIC INFUSION PUMPS MARKET, BY REGION,
2023–2030 (USD MILLION) 107
TABLE 27 NORTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 108
TABLE 28 NORTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 108
TABLE 29 NORTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 109
TABLE 30 NORTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023–2030 (USD MILLION) 109
TABLE 31 US: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 110
TABLE 32 US: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 110
TABLE 33 US: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY,
2023–2030 (USD MILLION) 111
TABLE 34 CANADA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 111
TABLE 35 CANADA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 112
TABLE 36 CANADA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023–2030 (USD MILLION) 112
TABLE 37 MEXICO: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 113
TABLE 38 MEXICO: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 113
TABLE 39 MEXICO: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023–2030 (USD MILLION) 113
TABLE 40 EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 115
TABLE 41 EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 115
TABLE 42 EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 115
TABLE 43 EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023–2030 (USD MILLION) 116
TABLE 44 GERMANY: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 117
TABLE 45 GERMANY: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 117
TABLE 46 GERMANY: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023–2030 (USD MILLION) 117
TABLE 47 FRANCE: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 118
TABLE 48 FRANCE: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 119
TABLE 49 FRANCE: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023–2030 (USD MILLION) 119
TABLE 50 UK: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 120
TABLE 51 UK: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 120
TABLE 52 UK: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY,
2023–2030 (USD MILLION) 120
TABLE 53 ITALY: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 121
TABLE 54 ITALY: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 121
TABLE 55 ITALY: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY,
2023–2030 (USD MILLION) 122
TABLE 56 SPAIN: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 123
TABLE 57 SPAIN: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 123
TABLE 58 SPAIN: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY,
2023–2030 (USD MILLION) 123
TABLE 59 REST OF EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 124
TABLE 60 REST OF EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 124
TABLE 61 REST OF EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023–2030 (USD MILLION) 125
TABLE 62 ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 126
TABLE 63 ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 126
TABLE 64 ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 126
TABLE 65 ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023–2030 (USD MILLION) 127
TABLE 66 CHINA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 128
TABLE 67 CHINA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 128
TABLE 68 CHINA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY,
2023–2030 (USD MILLION) 128
TABLE 69 JAPAN: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 129
TABLE 70 JAPAN: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 129
TABLE 71 JAPAN: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY,
2023–2030 (USD MILLION) 130
TABLE 72 INDIA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 131
TABLE 73 INDIA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 131
TABLE 74 INDIA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY,
2023–2030 (USD MILLION) 131
TABLE 75 SOUTH KOREA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 132
TABLE 76 SOUTH KOREA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 133
TABLE 77 SOUTH KOREA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023–2030 (USD MILLION) 133
TABLE 78 AUSTRALIA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 134
TABLE 79 AUSTRALIA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 134
TABLE 80 AUSTRALIA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023–2030 (USD MILLION) 134
TABLE 81 REST OF ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 135
TABLE 82 REST OF ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 135
TABLE 83 REST OF ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023–2030 (USD MILLION) 136
TABLE 84 SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 137
TABLE 85 SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 137
TABLE 86 SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 137
TABLE 87 SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023–2030 (USD MILLION) 138
TABLE 88 BRAZIL: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 139
TABLE 89 BRAZIL: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 139
TABLE 90 BRAZIL: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY,
2023–2030 (USD MILLION) 139
TABLE 91 ARGENTINA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 140
TABLE 92 ARGENTINA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 141
TABLE 93 ARGENTINA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023–2030 (USD MILLION) 141
TABLE 94 REST OF SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 142
TABLE 95 REST OF SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 142
TABLE 96 REST OF SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023–2030 (USD MILLION) 142
TABLE 97 MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 143
TABLE 98 MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 144
TABLE 99 MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 144
TABLE 100 MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023–2030 (USD MILLION) 144
TABLE 101 GCC COUNTRIES: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 145
TABLE 102 GCC COUNTRIES: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 145
TABLE 103 GCC COUNTRIES: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023–2030 (USD MILLION) 146
TABLE 104 SAUDI ARABIA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 147
TABLE 105 SAUDI ARABIA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 147
TABLE 106 SAUDI ARABIA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023–2030 (USD MILLION) 147
TABLE 107 UAE: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 148
TABLE 108 UAE: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 148
TABLE 109 UAE: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY,
2023–2030 (USD MILLION) 149
TABLE 110 REST OF GCC COUNTRIES: ELASTOMERIC INFUSION PUMPS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 150
TABLE 111 REST OF GCC COUNTRIES: ELASTOMERIC INFUSION PUMPS MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 150
TABLE 112 REST OF GCC COUNTRIES: ELASTOMERIC INFUSION PUMPS MARKET,
BY END-USE INDUSTRY, 2023–2030 (USD MILLION) 150
TABLE 113 SOUTH AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 151
TABLE 114 SOUTH AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 151
TABLE 115 SOUTH AFRICA: ELASTOMERIC INFUSION PUMPS MARKET,
BY END-USE INDUSTRY, 2023–2030 (USD MILLION) 152
TABLE 116 REST OF MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 152
TABLE 117 REST OF MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 153
TABLE 118 REST OF MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET,
BY END-USE INDUSTRY, 2023–2030 (USD MILLION) 153
TABLE 119 ELASTOMERIC INFUSION PUMPS MARKET: OVERVIEW OF MAJOR STRATEGIES ADOPTED BY KEY PLAYERS, JANUARY 2020–OCTOBER 2025 154
TABLE 120 ELASTOMERIC INFUSION PUMPS MARKET: DEGREE OF COMPETITION, 2024 157
TABLE 121 ELASTOMERIC INFUSION PUMPS MARKET: REGIONAL FOOTPRINT, 2024 165
TABLE 122 ELASTOMERIC INFUSION PUMPS MARKET: TYPE FOOTPRINT, 2024 166
TABLE 123 ELASTOMERIC INFUSION PUMPS MARKET: APPLICATION FOOTPRINT, 2024 166
TABLE 124 ELASTOMERIC INFUSION PUMPS MARKET: END-USE INDUSTRY FOOTPRINT, 2024 167
TABLE 125 ELASTOMERIC INFUSION PUMPS MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2024 169
TABLE 126 ELASTOMERIC INFUSION PUMPS MARKET: COMPETITIVE BENCHMARKING
OF KEY STARTUPS/SMES, 2024 170
TABLE 127 ELASTOMERIC INFUSION PUMPS MARKET: DEALS,
JANUARY 2020–OCTOBER 2025 172
TABLE 128 ELASTOMERIC INFUSION PUMPS MARKET: EXPANSIONS,
JANUARY 2020–OCTOBER 2025 173
TABLE 129 BAXTER: COMPANY OVERVIEW 175
TABLE 130 BAXTER: PRODUCTS/SOLUTIONS/SERVICES OFFERED 176
TABLE 131 B. BRAUN SE: COMPANY OVERVIEW 179
TABLE 132 B. BRAUN SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 180
TABLE 133 B. BRAUN SE: DEALS 182
TABLE 134 NIPRO: COMPANY OVERVIEW 183
TABLE 135 NIPRO: PRODUCTS/SOLUTIONS/SERVICES OFFERED 184
TABLE 136 NIPRO: DEALS 185
TABLE 137 NIPRO: EXPANSIONS 186
TABLE 138 AVNS: COMPANY OVERVIEW 188
TABLE 139 AVNS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 189
TABLE 140 VYGON: COMPANY OVERVIEW 192
TABLE 141 VYGON: PRODUCTS/SOLUTIONS/SERVICES OFFERED 192
TABLE 142 VYGON: DEALS 193
TABLE 143 VYGON: EXPANSIONS 193
TABLE 144 WOOYOUNG MEDICAL CO., LTD.: COMPANY OVERVIEW 195
TABLE 145 WOOYOUNG MEDICAL CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 195
TABLE 146 SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.: COMPANY OVERVIEW 197
TABLE 147 SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.: PRODUCTS/
SOLUTIONS/ SERVICES OFFERED 198
TABLE 148 SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.: DEALS 199
TABLE 149 AMBU A/S: COMPANY OVERVIEW 200
TABLE 150 AMBU A/S: PRODUCTS/SOLUTIONS/SERVICES OFFERED 201
TABLE 151 AMBU A/S: EXPANSIONS 202
TABLE 152 PALEX: COMPANY OVERVIEW 203
TABLE 153 PALEX: PRODUCTS/SOLUTIONS/SERVICES OFFERED 203
TABLE 154 PALEX: DEALS 204
TABLE 155 DAIKEN MEDICAL CO., LTD.: COMPANY OVERVIEW 205
TABLE 156 DAIKEN MEDICAL CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 206
TABLE 157 PROMECON GMBH: COMPANY OVERVIEW 207
TABLE 158 S&S MED: COMPANY OVERVIEW 208
TABLE 159 EPIC MEDICAL: COMPANY OVERVIEW 209
TABLE 160 MULTIMEDICAL S.R.L.: COMPANY OVERVIEW 210
TABLE 161 TECNOLINE S.P.A.: COMPANY OVERVIEW 211
TABLE 162 ZHEJIANG FERT MEDICAL DEVICE CO., LTD.: COMPANY OVERVIEW 212
TABLE 163 ACE MEDICAL: COMPANY OVERVIEW 213
TABLE 164 GAMASTECH SRL: COMPANY OVERVIEW 214
TABLE 165 FIRST MEDICAL SOURCE: COMPANY OVERVIEW 215
TABLE 166 DELTAMED: COMPANY OVERVIEW 216
TABLE 167 VIKYMED ITALIA SRL: COMPANY OVERVIEW 217
TABLE 168 CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.: COMPANY OVERVIEW 218
TABLE 169 MAIS INDIA: COMPANY OVERVIEW 219
TABLE 170 NARANG MEDICAL LIMITED: COMPANY OVERVIEW 220
TABLE 171 ZEBRA MEDICAL: COMPANY OVERVIEW 221
TABLE 172 INFUSION PUMPS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 232
TABLE 173 INFUSION PUMPS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 232
TABLE 174 INFUSION PUMPS MARKET, BY SETTING, 2020–2027 (USD MILLION) 233
TABLE 175 INFUSION PUMPS MARKET, BY REGION, 2020–2027 (USD MILLION) 234
LIST OF FIGURES
FIGURE 1 ELASTOMERIC INFUSION PUMPS MARKET SEGMENTATION AND REGIONAL SCOPE 23
FIGURE 2 KEY INSIGHTS AND MARKET HIGHLIGHTS 26
FIGURE 3 GLOBAL ELASTOMERIC INFUSION PUMPS MARKET, 2023–2030 26
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN ELASTOMERIC INFUSION PUMPS MARKET (2020–2025) 27
FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF ELASTOMERIC INFUSION
PUMPS MARKET DURING FORECAST PERIOD 28
FIGURE 6 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN ELASTOMERIC INFUSION PUMPS MARKET, 2024 29
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 30
FIGURE 8 HIGH DEMAND IN HOSPITALS AND HOMECARE SETTINGS TO CREATE
LUCRATIVE OPPORTUNITIES FOR MARKET PLAYERS 31
FIGURE 9 US DOMINATED ELASTOMERIC INFUSION PUMPS MARKET IN NORTH AMERICA 32
FIGURE 10 CONTINUOUS RATE SEGMENT DOMINATED ELASTOMERIC INFUSION
PUMPS MARKET IN 2024 32
FIGURE 11 PAIN MANAGEMENT SEGMENT ACCOUNTED FOR LARGEST SHARE OF ELASTOMERIC INFUSION PUMPS MARKET IN 2024 33
FIGURE 12 HOSPITALS SEGMENT ACCOUNTED FOR LARGEST SHARE OF ELASTOMERIC INFUSION PUMPS MARKET IN 2024 33
FIGURE 13 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 34
FIGURE 14 ELASTOMERIC INFUSION PUMPS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 35
FIGURE 15 US CANCER SURVIVORS (MALE & FEMALE) BY YEARS SINCE DIAGNOSIS,
AS OF JANUARY 2025 36
FIGURE 16 ELASTOMERIC INFUSION PUMPS MARKET: PORTER’S FIVE FORCES ANALYSIS 45
FIGURE 17 ELASTOMERIC INFUSION PUMPS MARKET: VALUE CHAIN ANALYSIS 49
FIGURE 18 ELASTOMERIC INFUSION PUMPS MARKET: ECOSYSTEM ANALYSIS 51
FIGURE 19 AVERAGE SELLING PRICE OF KEY PLAYERS, BY TYPE, 2024 52
FIGURE 20 AVERAGE SELLING PRICE TREND OF ELASTOMERIC INFUSION PUMPS,
BY REGION, 2023–2030 53
FIGURE 21 EXPORT SCENARIO FOR HS CODE 901890-COMPLIANT PRODUCTS,
BY COUNTRY, 2020–2024 54
FIGURE 22 IMPORT SCENARIO FOR HS CODE 901890-COMPLIANT PRODUCTS,
BY COUNTRY, 2020–2024 55
FIGURE 23 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 57
FIGURE 24 INVESTMENT AND FUNDING SCENARIO, 2018–2024 58
FIGURE 25 LIST OF MAJOR PATENTS FOR ELASTOMERIC INFUSION PUMPS, 2015–2024 69
FIGURE 26 MAJOR PATENTS APPLIED AND GRANTED RELATED TO ELASTOMERIC INFUSION PUMPS, BY COUNTRY/REGION, 2015–2024 69
FIGURE 27 ELASTOMERIC INFUSION PUMPS MARKET DECISION-MAKING FACTORS 87
FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END-USE INDUSTRY 88
FIGURE 29 KEY BUYING CRITERIA, BY END-USE INDUSTRY 89
FIGURE 30 ADOPTION BARRIERS & INTERNAL CHALLENGES 90
FIGURE 31 CONTINUOUS RATE SEGMENT TO DOMINATE ELASTOMERIC INFUSION
PUMPS MARKET DURING FORECAST PERIOD 94
FIGURE 32 PAIN MANAGEMENT TO ACCOUNT FOR LARGEST SHARE OF
ELASTOMERIC INFUSION PUMPS MARKET IN 2025 97
FIGURE 33 HOSPITALS TO BE LARGEST END-USE INDUSTRY OF ELASTOMERIC
INFUSION PUMPS IN 2025 101
FIGURE 34 CHINA TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD 106
FIGURE 35 NORTH AMERICA TO ACCOUNT FOR LARGEST SHARE OF ELASTOMERIC
INFUSION PUMPS MARKET IN 2025 106
FIGURE 36 NORTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET SNAPSHOT 108
FIGURE 37 EUROPE: ELASTOMERIC INFUSION PUMPS MARKET SNAPSHOT 114
FIGURE 38 ELASTOMERIC INFUSION PUMPS: MARKET SHARE ANALYSIS, 2024 156
FIGURE 39 ELASTOMERIC INFUSION PUMPS MARKET: REVENUE ANALYSIS
OF KEY COMPANIES, 2020–2024 159
FIGURE 40 ELASTOMERIC INFUSION PUMPS MARKET: COMPANY VALUATION, 2024 160
FIGURE 41 ELASTOMERIC INFUSION PUMPS MARKET: FINANCIAL MATRIX: EV/
EBITDA RATIO, 2024 160
FIGURE 42 ELASTOMERIC INFUSION PUMPS MARKET: YEAR-TO-DATE PRICE
AND FIVE-YEAR STOCK BETA, 2024 161
FIGURE 43 ELASTOMERIC INFUSION PUMPS MARKET: PRODUCT/BRAND COMPARISON 162
FIGURE 44 ELASTOMERIC INFUSION PUMPS MARKET: COMPANY EVALUATION
MATRIX (KEY PLAYERS), 2024 164
FIGURE 45 ELASTOMERIC INFUSION PUMPS MARKET: COMPANY FOOTPRINT, 2024 165
FIGURE 46 ELASTOMERIC INFUSION PUMPS MARKET: COMPANY EVALUATION
MATRIX (STARTUPS/SMES), 2024 168
FIGURE 47 BAXTER: COMPANY SNAPSHOT 176
FIGURE 48 B. BRAUN SE: COMPANY SNAPSHOT 180
FIGURE 49 NIPRO: COMPANY SNAPSHOT 184
FIGURE 50 AVNS: COMPANY SNAPSHOT 189
FIGURE 51 SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.: COMPANY SNAPSHOT 198
FIGURE 52 AMBU A/S: COMPANY SNAPSHOT 201
FIGURE 53 DAIKEN MEDICAL CO., LTD.: COMPANY SNAPSHOT 205
FIGURE 54 ELASTOMERIC INFUSION PUMPS MARKET: RESEARCH DESIGN 222
FIGURE 55 BREAKDOWN OF INTERVIEWS WITH EXPERTS 225
FIGURE 56 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 226
FIGURE 57 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 226
FIGURE 58 ELASTOMERIC INFUSION PUMPS MARKET: APPROACH 1 227
FIGURE 59 ELASTOMERIC INFUSION PUMPS MARKET: APPROACH 2 227
FIGURE 60 ELASTOMERIC INFUSION PUMPS MARKET: DATA TRIANGULATION 228
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11